Cellular and T cell engager Immunotherapy
Characteristics of Bridging Therapy and Impact of Pre-lymphodepletion Tumor Burden on Clinical Outcomes of Idecabtagene Vicleucel
Doris K. Hansen, MD
Assistant Professor
Moffiitt Cancer Center
Tampa, Florida, United States